1. Pecoraro, S., A. Annecchiarico, M. C. Gambardella, and G. Sepe. Efficacy of pretreatment with Serenoa repens on bleeding associated with transurethral resection of prostate. Minerva Urol Nefrol 2004; 56(1): 73–78.
2. Debruyne, F., P. Boyle, F. Calais Da Silva, et al. Evaluation of the clinical benefit of permixon and tamsulosin in severe BPH patients-PERMAL study subset analysis. Eur Urol 2004; 45(6): 773–779.
3. Boyle, P., C. Robertson, F. Lowe, and C. Roehrborn. Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia. BJU Int 2004; 93(6): 751–756.
4. Markowitz, J. S., J. L. Donovan, C. L. Devane, et al. Multiple doses of saw palmetto (Serenoa repens) did not alter cytochrome P450 2D6 and 3A4 activity in normal volunteers. Clin Pharmacol Ther 2003; 74(6): 536–542.
5. Vela Navarrete, R., J. V. Garcia Cardoso, A. Barat, F. Manzarbeitia, and A. Lopez Farre. BPH and inflammation: pharmacological effects of Permixon on histological and molecular inflammatory markers. Results of a double blind pilot clinical assay. Eur Urol 2003; 44(5): 549–555.